ViruSure Launches New Viral Test Using Nanopore Tech
New adventitious viral agent (AVA) detection test offers rapid, sensitive, and affordable viral screening for biomanufacturers ViruSure, a global leader in pathogen safety testing for biopharmaceuticals, and Oxford Nanopore Technologies (“Oxford Nanopore”) (LSE: ONT), the company behind a new generation of molecular sensing technology based on nanopores, today announce the launch of the industry’s first…
